Navigation Links
Immunotherapy Offers New Hope for Cancer Patients: One Man’s Alternative Cancer Treatment Journey
Date:12/23/2013

Simpsonville, SC (PRWEB) December 23, 2013

It started as a mole on his leg, and spread quickly, despite aggressive chemotherapy and surgery. When 59-year-old Ray Merrill learned his melanoma was incurable and amputation of his leg was the only option available to buy just a little more time, he prayed for another solution. The alternative cancer treatment he found at Perseus PCI earlier this fall was literally the answer to his prayers, keeping his limb intact while bringing him immediate relief from pain, and in December, an extensive imaging test showed came back clear, showing no evidence of disease.

“My oncologist couldn’t believe it!” marvels Merrill. “Just a few months ago, I was headed straight to Stage 4 melanoma, with nothing but pain in the future. I was devastated, thinking I had no chance to see my 14-year-old daughter grow up.”

After receiving his ‘incurable’ diagnosis this fall, Merrill was determined not to spend whatever time he had left undergoing toxic chemotherapy regimens, or being bedridden after major surgery. Through his own extensive research and outreach, he learned of the Perseus PCI cancer vaccine.

“When I heard how it caused no side effects, I thought it was almost too easy to be real,” remembers Merrill. “Many people agreed with that conclusion and tried to talk me out of it, but I felt that this option was absolutely what I needed to do – it made sense and I was determined to try it. Hearing Dr. Wagner speak lifted my spirits and gave me hope, knowing there was a chance to beat this.”

Four months later, after completing the series of monthly inoculations, the soft-spoken Georgian native is certain his decision was the right, life-affirming one. From first to final treatment, all went smoothly, exactly as planned, and the most recent, completely
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Argos Therapeutic Arcelis™ Immunotherapy AGS-003 in Combination With Sunitinib Shows Statistically Significant Correlation of Immune System Response to Overall Survival in Phase 2 Study in Patients with Advanced Renal Cell Carcinoma (RCC)
2. Cancer Immunotherapy Expert Joins Pacific Meso Center Research Team
3. UroToday Launches New Prostate Cancer Focused Content Including Immunotherapy for Metastatic Castration-resistant Patients
4. Tuberculosis Immunotherapy Grant for Immunoxel Honibe Honey Lozenges
5. Advanced Cell Diagnostics Initiates Agreement to Study Biomarkers for Cancer Immunotherapy
6. FDA Review in Journal for ImmunoTherapy of Cancer Offers New Insights into Cancer Immunotherapy Product Development & Clinical Evaluation
7. Argos Therapeutics Presents Data Showing Memory T Cell Expansion After Administration of Fully Personalized Immunotherapy Correlates with Overall Survival Benefit in Patients with Metastatic Renal Cell Carcinoma
8. Leading Cancer Research Centers Team Up To Launch Biotech Startup Focused On Cancer Immunotherapy
9. Fortis Offers Bachelor of Science in Nursing Degree Program to Florida Students
10. Gundersen Lutheran Offers Heart Surgery with Less Pain, Faster Recovery
11. UH Case Medical Center Offers New Therapy for Gynecologic Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... , June 29, 2015  AACC, a ... better health through laboratory medicine, is pleased to ... Clinical Chemistry , has increased to 7.9 ... This increase places Clinical Chemistry in ... reflects the significant influence of the research it ...
(Date:6/29/2015)... , June 29, 2015   Veracyte, Inc . ... the field of molecular cytology, today announced that it ... prestigious Top Workplaces list for the second year in ... based solely on an annual survey of Bay Area-company ... that the degree to which Veracyte values our employees ...
(Date:6/26/2015)... /PRNewswire/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... listed in the management information circular dated June 1, ... Meeting of Shareholders, held earlier today, June 26 ... 5 nominees proposed by management were elected as ... Company,s next Annual Meeting of Shareholders or until ...
(Date:6/26/2015)... 23, 2015 Research ... of the "Global Cancer Biosimilars Market Opportunity ... Market introduction of cancer biosimilar is required because ... Chemotherapeutic drugs have dominated the cancer segment for ... introduced in past few years. They are biologic ...
Breaking Biology Technology:AACC's Journal, Clinical Chemistry, Continues to Have Significant Impact on Medical Testing, Healthcare 2AACC's Journal, Clinical Chemistry, Continues to Have Significant Impact on Medical Testing, Healthcare 3Veracyte Named a 2015 "Top Workplace" in the San Francisco Bay Area 2Veracyte Named a 2015 "Top Workplace" in the San Francisco Bay Area 3iCo Therapeutics Announces Voting & Election Results from Annual Meeting of Shareholders 2iCo Therapeutics Announces Voting & Election Results from Annual Meeting of Shareholders 3Global Cancer Biosimilars Market Opportunity Outlook 2Global Cancer Biosimilars Market Opportunity Outlook 3
... trees pull vast amounts of water from their roots up ... capillary action, but now scientists at the University of Rochester ... using the same principlebut does so at a speed that ... upcoming issue of Applied Physics Letters , may prove ...
... (Nasdaq: VPHM ) today announced that Colin Broom, ... present at the 30th Annual Goldman Sachs Global Healthcare Conference ... The conference is being held at the Grand Hyatt in ... William Roberts, vice president, corporate communications will present at the ...
... BASKING RIDGE, N.J., June 2 Regado Biosciences, Inc., ... therapeutic aptamers with active control agents, today announced the ... MAB is comprised of leaders in the fields of ... highly regarded leaders will advise the Company on its ...
Cached Biology Technology:Scientists create metal that pumps liquid uphill 2Scientists create metal that pumps liquid uphill 3ViroPharma to Present at Two June Healthcare Conferences 2Regado Biosciences Establishes Medical Advisory Board 2Regado Biosciences Establishes Medical Advisory Board 3
(Date:6/16/2015)... , June 16, 2015 Fingerprint ... previously communicated that it will amount to at least 340 ... Due to the rapid increase in market growth and orders ... previously communicated guidance that revenue for 2015 will exceed 1,500 ... amount to approximately 2,200 MSEK. Due to receipt ...
(Date:6/11/2015)... June 11, 2015 Daon, a global ... that its IdentityX Mobile Authentication Platform v4.0 has ... Alliance is an industry consortium launched in 2013 ... simpler, stronger authentication.  In order to receive certification, ... rigorous series of tests that measure compliance and ...
(Date:6/8/2015)...  The Secure Identity & Biometrics Association ... Troy Potter of L-3 National Security Solutions ... non-profit association that was established in February 2014 ... of solutions that protect and secure identity across ... Photo - ...
Breaking Biology News(10 mins):Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3Daon's IdentityX Mobile Authentication Platform One of First Products to be Certified by FIDO Alliance 2Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 2Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 3Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 4Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 5
... of our daily vocabulary. We all know they,re part of ... We know they have something to do with starches and ... a lot for science to learn about them. ... Nikki Pohl, an Iowa State University associate professor of chemistry. ...
... UC Davis Cancer Center shows that a protein called Muc4 ... spread to other organs and resist therapeutic treatment. The study, ... Research , is one of the first to characterize the ... author of the study, knew that Muc4 was not always ...
... worldwide trade organisation bringing together users and manufacturers of ... Cavimeter was judged by the panel to be "more ... culmination of a period of research, development and exploitation ... Acoustic cavitation is the inception, growth and eventual collapse ...
Cached Biology News:Iowa State chemist synthesizes carbohydrates, launches startup company 2UC Davis researchers identify a protein that may help breast cancer spread, beat cancer drugs 2NPL Cavimeter receives 2009 UIA Outstanding Product Award 2
...
... 500 optimization kit is for fine-tuning the ... The kit is recommended when you are ... The kit includes 0.25 g each of ... diameter gold microcarriers, 100 each of 9 ...
... is specifically designed for two-dimensional electrophoresis ... four proteins in this marker have ... pattern across a 2D gel. The ... Mol wt: 17,000-89,000 ...
... Blocker Arrays can be used to test ... proteins and sera that are commonly used ... array contains spots for 21 different protein ... of antibody crossreactivity and species specificity, QC ...
Biology Products: